| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) S Miyakis, MD Lockshin, T Atsumi, DW Branch, RL Brey, R Cervera, ... Journal of thrombosis and haemostasis 4 (2), 295-306, 2006 | 8801 | 2006 |
| Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). HP McNeil, RJ Simpson, CN Chesterman, SA Krilis Proceedings of the National Academy of Sciences 87 (11), 4120-4124, 1990 | 2252 | 1990 |
| The pathogenesis of the antiphospholipid syndrome B Giannakopoulos, SA Krilis New England Journal of Medicine 368 (11), 1033-1044, 2013 | 836 | 2013 |
| Immunology and clinical importance of antiphospholipid antibodies HP McNeil, CN Chesterman, SA Krilis Advances in immunology 49, 193-280, 1991 | 702 | 1991 |
| Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th … G Ruiz-Irastorza, MJ Cuadrado, I Ruiz-Arruza, R Brey, M Crowther, ... Lupus 20 (2), 206-218, 2011 | 632 | 2011 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 409 | 2023 |
| The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Hunt, S Krilis Journal of immunology (Baltimore, Md.: 1950) 152 (2), 653-659, 1994 | 376 | 1994 |
| A phospholipid-β2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection JE Hunt, HP McNeil, GJ Morgan, RM Crameri, SA Krilis Lupus 1 (2), 75-81, 1992 | 361 | 1992 |
| Current concepts on the pathogenesis of the antiphospholipid syndrome B Giannakopoulos, F Passam, S Rahgozar, SA Krilis Blood 109 (2), 422-430, 2007 | 349 | 2007 |
| PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome G Marchal, P Rioux, MC Petit-Tabou, JM Derlon, JC Baron, C Serrati, ... The Lancet 341 (8850), 925-927, 1993 | 297 | 1993 |
| Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population W Shi, SA Krilis, BH Chong, S Gordon, CN Chesterman Australian and New Zealand journal of medicine 20 (3), 231-236, 1990 | 270 | 1990 |
| Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. JE Hunt, RJ Simpson, SA Krilis Proceedings of the National Academy of Sciences 90 (6), 2141-2145, 1993 | 265 | 1993 |
| How we diagnose the antiphospholipid syndrome B Giannakopoulos, F Passam, Y Ioannou, SA Krilis Blood, The Journal of the American Society of Hematology 113 (5), 985-994, 2009 | 260 | 2009 |
| β2‐Glycoprotein I: evolution, structure and function PG De Groot, JCM Meijers Journal of Thrombosis and Haemostasis 9 (7), 1275-1284, 2011 | 259 | 2011 |
| β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of “Non-self” Particles (∗) A Chonn, SC Semple, PR Cullis Journal of Biological Chemistry 270 (43), 25845-25849, 1995 | 256 | 1995 |
| Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics HP McNeil, CN Chesterman, SA Krilis British Journal of Haematology 73 (4), 506-513, 1989 | 235 | 1989 |
| Anti–β2‐glycoprotein I antibodies in complex with β2‐glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib‐IX‐V T Shi, B Giannakopoulos, X Yan, P Yu, MC Berndt, RK Andrews, J Rivera, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 220 | 2006 |
| Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing J Douaiher, J Succar, L Lancerotto, MF Gurish, DP Orgill, MJ Hamilton, ... Advances in immunology 122, 211-252, 2014 | 215 | 2014 |
| Coronary artery bypass graft failure—an autoimmune phenomenon? KE Morton, SA Krilis, DW Baron, TP Gavaghan, GE Daggard, JB Hickie, ... The Lancet 328 (8520), 1353-1357, 1986 | 210 | 1986 |
| Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin … Y Sheng, A Sali, H Herzog, J Lahnstein, SA Krilis Journal of immunology (Baltimore, Md.: 1950) 157 (8), 3744-3751, 1996 | 201 | 1996 |